🇫🇷
France · FR · FR:60245253
REVLIMID 10 mg, gélule
ATC L04AX04
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerBRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
CountryFR (France)
ATC codeL04AX04
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 2
- cip133400930108253plaquette(s) thermoformée(s) PVC polychlortrifluoroéthylène aluminium de 7 gélule(s)
- cip133400938102314plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC aluminium de 21 gélule(s)
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "60245253",
"date_amm": "2007-06-14",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/07/391",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code L04AX04.
Access this data programmatically
Query REVLIMID 10 mg, gélule and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.